These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8052963)

  • 1. New immunocapture enzyme (ICE) assay for quantification of cancer procoagulant activity: studies of inhibitors.
    Mielicki WP; Tagawa M; Gordon SG
    Thromb Haemost; 1994 Apr; 71(4):456-60. PubMed ID: 8052963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker.
    Gordon SG; Cross BA
    Cancer Res; 1990 Oct; 50(19):6229-34. PubMed ID: 2169340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer procoagulant--CP.
    Rucińska M; Gacko M; Skrzydlewski Z
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():110-7. PubMed ID: 9337529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of divalent ions on the activity of cancer procoagulant.
    Mielicki WP; Kozwich DL; Kramer LC; Gordon SG
    Arch Biochem Biophys; 1994 Oct; 314(1):165-70. PubMed ID: 7944389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum.
    Rucińska M; Furman M; Skrzydlewski Z; Zaremba E
    Acta Biochim Pol; 1997; 44(1):109-12. PubMed ID: 9241361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic significance of cancer procoagulant activity in colorectal cancer].
    Kozuszko B; Skrzydlewski Z; Famulski W
    Pol Merkur Lekarski; 2000 Mar; 8(45):127-8. PubMed ID: 10870414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
    Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemistry of cancer procoagulant.
    Mielicki WP
    Haemostasis; 2001; 31 Suppl 1():8-10. PubMed ID: 11990487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of the efficacy of cancer procoagulant (CP) activity evaluation in the oncological diagnosis of the urinary system].
    Szajda SD; Darewicz B; Kudelski J; Werel T; Zwierz K; Skrzydlewski Z; Gabrylewski W
    Pol Merkur Lekarski; 2005 Oct; 19(112):596-9. PubMed ID: 16379335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein A immunocapture assay detecting antibodies to fluke cysteine proteinases for immunodiagnosis of human paragonimiasis and fascioliasis.
    Ikeda T
    J Helminthol; 2001 Sep; 75(3):245-9. PubMed ID: 11551314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer].
    Szajda SD; Darewicz B; Kudelski J; Chlabicz M; Domel T; Chabielska E; Skrzydlewski Z
    Pol Merkur Lekarski; 2005 Jun; 18(108):651-3. PubMed ID: 16124376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cancer procoagulant--biochemical characteristics and the influence on the development of neoplastic disease].
    Kamocka M; Mielicki WP
    Postepy Biochem; 2003; 49(3):168-74. PubMed ID: 15083609
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.
    Gordon SG; Mielicki WP
    Blood Coagul Fibrinolysis; 1997 Mar; 8(2):73-86. PubMed ID: 9518049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.
    Kos J; Krasovec M; Cimerman N; Nielsen HJ; Christensen IJ; Brünner N
    Clin Cancer Res; 2000 Feb; 6(2):505-11. PubMed ID: 10690531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer procoagulant (CP)].
    Szajda SD; Darewicz B; Gorzel M; Zalewska B; Skrzydlewski Z; Kudelski J; Domel T
    Przegl Lek; 2005; 62(3):169-72. PubMed ID: 16171148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatically active cathepsin B dissociating from its inhibitor complexes is elevated in blood plasma of patients with septic shock and some malignant tumors.
    Assfalg-Machleidt I; Jochum M; Klaubert W; Inthorn D; Machleidt W
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():263-9. PubMed ID: 3202966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a warfarin-sensitive cancer procoagulant in V2 carcinoma.
    Roncaglioni MC; Falanga A; D'Alessandro AP; Alessio MG; Casali B; Donati MB
    Haematologica; 1989; 74(2):143-7. PubMed ID: 2501168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo studies of ICE inhibitors.
    Livingston DJ
    J Cell Biochem; 1997 Jan; 64(1):19-26. PubMed ID: 9015750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute lymphoblastic leukemia (ALL) and cancer procoagulant activity.
    Pogliani EM; Lanzafame C; Bucciarelli P; Corneo G
    Haematologica; 1991; 76(6):526-7. PubMed ID: 1688361
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer procoagulant (CP) in lung cancer.
    Rucińska M; Skrzydlewski Z; Zaremba E; Furman M; Kasacka I
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():251-3. PubMed ID: 9337542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.